Atlas Wealth’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-780,335
Closed -$13M 88
2024
Q2
$13M Buy
+780,335
New +$12.5M 1.52% 18
2023
Q4
Sell
-542,642
Closed -$7.86M 83
2023
Q3
$7.86M Sell
542,642
-5,995
-1% -$89.7K 1.47% 24
2023
Q2
$8.36M Sell
548,637
-1,888
-0.3% -$28.4K 1.54% 21
2023
Q1
$8.33M Sell
550,525
-20,787
-4% -$308K 1.64% 19
2022
Q4
$7.92M Buy
+571,312
New +$8.06M 2.14% 15

Other funds holding BCAT

Atlas Wealth's BCAT Position: Q3 2024 in Review

Atlas Wealth sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q3 2024, closing a stake of 780,335 shares — an estimated $13M sold.

Atlas Wealth first reported a position in BCAT in Q4 2022 and held it in 5 quarters. The position peaked at $13M in Q2 2024. 80 funds tracked by Wall St. Rank hold BCAT as of Q3 2024.

  • Atlas Wealth reported no remaining BlackRock Capital Allocation Term Trust position as of Q3 2024 after selling out during the quarter.
  • Atlas Wealth sold 780,335 BlackRock Capital Allocation Term Trust shares in Q3 2024, an estimated $13M.
  • Atlas Wealth first reported a position in BlackRock Capital Allocation Term Trust in Q4 2022 and held it in 5 quarters.
  • Atlas Wealth's BlackRock Capital Allocation Term Trust position peaked at $13M in Q2 2024.
  • 80 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q3 2024.

Based on Atlas Wealth's 13F filing for Q3 2024, filed 14 Nov 2024.